one) and Drug Interactions (7)]. The potential risk of hypoglycemia could be decreased by a discount during the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Tell people making use of these concomitant medications of the potential risk of hypoglycemia and educate them around the signs and signs or sympt